![Michael Rome](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Rome
Directeur/Membre du Conseil chez
Remix Therapeutics, Inc.
Profil
Michael Rome is currently Director at Remix Therapeutics, Inc., Director at Pharvaris GmbH since 2020, Director at XinThera, Inc. since 2021, and Managing Director at Foresite Capital Management LLC since 2016.
Former positions include Director at Maze Therapeutics, Inc. and Alumis, Inc., Director at Pharvaris NV from 2019 to 2020, Independent Director at Theseus Pharmaceuticals, Inc. from 2021 to 2024, Independent Director at Kinnate Biopharma, Inc. from 2019 to 2024, and Director & Vice President at FS Development Corp.
from 2020 to 2021.
Education includes a doctorate from California Institute of Technology and an undergraduate degree from the University of California.
Postes actifs de Michael Rome
| Sociétés | Poste | Début |
|---|---|---|
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Private Equity Investor | 01/08/2016 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/07/2020 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Directeur/Membre du Conseil | - |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Michael Rome
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Directeur/Membre du Conseil | 03/04/2024 |
| THESEUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/02/2024 |
| FS DEVELOPMENT CORP. | Directeur/Membre du Conseil | 01/02/2021 |
| PHARVARIS N.V. | Directeur/Membre du Conseil | 31/12/2020 |
| ALUMIS INC. | Directeur/Membre du Conseil | - |
Formation de Michael Rome
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements. | Finance |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
FS Development Corp.
 FS Development Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Xinthera, Inc.
Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs | Health Technology |
